This is a continuing application for a 5-5 1/2 year Ph.D. (only) program in the Pharmacological Sciences. The first year of training in biomedical sciences at Vanderbilt University Medical Center is Interdisciplinary, and involves participation in a year long core curriculum. Students who select preceptors in the Pharmacological Sciences Training Program in May of their first year then begin the required course work for this graduate program, including: Systems, Targets, and Drug Action (includes in vivo physiology, drug disposition, and principles of drug action);Receptors and Signal Transduction;Scientific Communications;and Biostatistics. In addition, students take at least six additional hours of elective courses to accommodate individual interests and needs. Research opportunities are available in several areas: Receptor Mechanisms and Signal Transduction, Molecular mechanisms for Cellular Regulation, Neuropharmacology, Cardiovascular Pharmacology, Pharmacology of Arachidonic Acid Metabolites, and Drug Disposition and Pharmacokinetics. Course work is complemented by other important didactic experiences: weekly Journal Club;a student- invited annual Pharmacology Forum;an annual Department of Pharmacology Retreat for presenting upcoming research goals;and exchange programs between Vanderbilt and Meharry Medical College to strengthen the broad-based education of our students as well as to foster the careers of under-represented minorities in research. Comprehensive qualifying examinations and defense of the dissertation proposal precedes dissertation research;dissertation committee meetings occur frequently, to facilitate mentoring. The breadth of interest of the faculty, their international recognition and success in acquiring extramural peer-reviewed support, their understanding of the scientific process and our emphasis on scientific integrity make our program an outstanding environment for the training of independent scientists in the area of pharmacological sciences.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007628-35
Application #
8291075
Study Section
Special Emphasis Panel (ZGM1-BRT-5 (TG))
Program Officer
Okita, Richard T
Project Start
1978-07-01
Project End
2013-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
35
Fiscal Year
2012
Total Cost
$440,822
Indirect Cost
$21,226
Name
Vanderbilt University Medical Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Freyberg, Zachary; Sonders, Mark S; Aguilar, Jenny I et al. (2016) Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain. Nat Commun 7:10652
Ma, Yufang; Wang, Lihong; Neitzel, Leif R et al. (2016) The MAPK pathway regulates intrinsic resistance to BET inhibitors in colorectal cancer. Clin Cancer Res :
Gibson, Elizabeth G; King, McKenzie M; Mercer, Susan L et al. (2016) Two-Mechanism Model for the Interaction of Etoposide Quinone with Topoisomerase IIα. Chem Res Toxicol 29:1541-8
Nickols, Hilary Highfield; Yuh, Joannes P; Gregory, Karen J et al. (2016) VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy. J Pharmacol Exp Ther 356:123-36
Bermingham, Daniel P; Hardaway, J Andrew; Snarrenberg, Chelsea L et al. (2016) Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivo. Neurochem Int 98:122-8
Zhou, Jibin; Ahmad, Firdos; Parikh, Shan et al. (2016) Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy. Circ Res 118:1208-22
Gong, Yuanying; Ma, Yufang; Sinyuk, Maksim et al. (2016) Insulin-mediated signaling promotes proliferation and survival of glioblastoma through Akt activation. Neuro Oncol 18:48-57
Zurawski, Zack; Rodriguez, Shelagh; Hyde, Karren et al. (2016) Gβγ Binds to the Extreme C Terminus of SNAP25 to Mediate the Action of Gi/o-Coupled G Protein-Coupled Receptors. Mol Pharmacol 89:75-83
Loganathan, Sudan N; Tang, Nan; Fleming, Jonathan T et al. (2016) BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma. Oncotarget 7:43504-43517
Crouch, Rachel D; Morrison, Ryan D; Byers, Frank W et al. (2016) Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity. Drug Metab Dispos 44:1296-303

Showing the most recent 10 out of 147 publications